文献速递甲状腺疾病性腺与生殖内分泌

放射性碘治疗对女性甲状腺癌患者卵巢功能与生育力的影响:系统综述与荟萃分析

The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
PubMed 文献 · Thyroid · 2020-11-02

该系统综述与荟萃分析纳入22项研究,评估放射性碘(RAI)对女性分化型甲状腺癌患者卵巢功能与生育力的影响。多数研究显示RAI后第一年月经不规律发生率为12%至31%,闭经约8%至16%;RAI组绝经年龄稍早(49.5岁 vs 51岁,p<0.001),AMH水平在RAI后显著下降(平均差1.50 ng/mL),但荟萃分析未显示RAI患者妊娠风险降低。

要点

  • RAI后第一年月经不规律发生率达12%–31%,闭经约8%–16%。
  • RAI组绝经年龄稍早(49.5岁 vs 51岁,p<0.001),AMH水平显著下降。
  • 荟萃分析未显示RAI患者妊娠风险降低,但需前瞻性研究确认。

核心结论

  • 多数研究认为RAI治疗未导致长期妊娠率下降,但荟萃分析显示RAI后AMH水平显著降低。
  • 建议向患者咨询131I可能的影响,并将现有知识纳入多学科咨询。

研究设计与样本

  • 系统检索PubMed、Embase和Web of Science数据库至2020年1月,共纳入22项研究,多数为回顾性设计。
  • 对RAI后AMH水平、RAI前后1年AMH比较及RAI与未RAI患者的妊娠率进行荟萃分析。

主要发现

  • RAI后第一年月经不规律发生率为12%至31%,闭经发生率为8%至16%。
  • 接受RAI治疗(中位剂量3700 MBq,范围1110–40,700 MBq)的女性绝经年龄稍早于未接受RAI者(49.5岁 vs 51岁,p<0.001)。
  • 7项研究报告RAI后AMH汇总浓度为1.79 ng/mL。
  • 4项研究报告RAI前与RAI后1年AMH浓度,平均差异为1.50 ng/mL,具显著性。
  • 荟萃分析显示接受RAI的患者妊娠风险未降低。

临床怎么用

  • 对接受RAI治疗的女性甲状腺癌患者,应告知卵巢功能可能受影响及生育力咨询。
  • 建议将RAI对生育和卵巢功能的潜在影响纳入多学科咨询内容。

局限性

  • 多数纳入研究为回顾性设计,需前瞻性研究确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction: Thyroid cancer is one of the most common carcinomas diagnosed in adolescents and young adults, with a rapidly rising incidence for the past three decades. Surgery is the standard treatment for patients with differentiated thyroid carcinoma (DTC), and when indicated, followed by radioactive iodine (RAI) treatment. The aim of this study was to evaluate the possible effects of RAI therapy on ovarian function and fertility in women. Methods: The PubMed, Embase, and Web of Science databases were systematically searched up to January 2020. In addition, a meta-analyses were performed for anti-Mullerian hormone (AMH) levels after RAI, comparison of AMH levels prior and 1 year after RAI, and pregnancy rates in patient with thyroid cancer receiving RAI compared with patients with thyroid cancer who did not receive RAI. Results: A total of 36 studies were eligible for full-text screening and 22 studies were included. The majority of the studies had a retrospective design. Menstrual irregularities were present in the first year after RAI in 12% and up to 31% of the patients. Approximately 8-16% of the patients experienced amenorrhea in the first year after RAI. Women who received RAI treatment (median dose 3700 MBq [range 1110-40,700 MBq]); had menopause at a slightly younger age compared with women who did not receive RAI treatment, 49.5 and 51 years, respectively (p < 0.001). Pooled AMH of the seven studies reporting AMH concentrations after RAI was 1.79 ng/mL. Of these, four studies reported AMH concentrations prior and 1 year after RAI. The mean difference was 1.50 ng/mL, which was significant. Finally, meta-analysis showed that patients undergoing RAI were not at a decreased risk of becoming pregnant. Conclusions: Most of the studies indicate that RAI therapy for DTC is not associated with a long-term decrease in pregnancy rates although meta-analyses show a significant decrease in AMH levels after RAI therapy. Prospective studies are needed to confirm these results. We recommend counseling patients about the possible effects of 131I and incorporate today's knowledge in multidisciplinary counseling.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Piek MW, Postma EL, van Leeuwaarde R, et al. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis. Thyroid. 2020. PMID: 33012254. doi:10.1089/thy.2020.0356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。